Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

A Van Der Jagt; J L Muirhead; John F Seymour; Kenneth F Bradstock; Eldho Paul; Andrew Wei

doi:10.1038/leu.2011.201

Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

A Van Der Jagt, J L Muirhead, John F Seymour, Kenneth F Bradstock, Eldho Paul, Andrew Wei

Research output: Contribution to journal › Letter › Other

4 Citations (Scopus)

Abstract

N/A

Original language	English
Pages (from-to)	362 - 365
Number of pages	4
Journal	Leukemia
Volume	26
Issue number	2
DOIs	https://doi.org/10.1038/leu.2011.201
Publication status	Published - 2012

Access to Document

10.1038/leu.2011.201

Cite this

@article{487006db071b4058a17465ed4a1eb5b2,

title = "Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML",

abstract = "N/A",

author = "{Van Der Jagt}, A and Muirhead, {J L} and Seymour, {John F} and Bradstock, {Kenneth F} and Eldho Paul and Andrew Wei",

year = "2012",

doi = "10.1038/leu.2011.201",

language = "English",

volume = "26",

pages = "362 -- 365",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

AU - Van Der Jagt, A

AU - Muirhead, J L

AU - Seymour, John F

AU - Bradstock, Kenneth F

AU - Paul, Eldho

AU - Wei, Andrew

PY - 2012

Y1 - 2012

N2 - N/A

AB - N/A

UR - http://www.nature.com.ezproxy.lib.monash.edu.au/leu/journal/v26/n2/full/leu2011201a.html

U2 - 10.1038/leu.2011.201

DO - 10.1038/leu.2011.201

M3 - Letter

SN - 0887-6924

VL - 26

SP - 362

EP - 365

JO - Leukemia

JF - Leukemia

IS - 2

ER -

Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML

Abstract

Access to Document

Other files and links

Cite this